Skip to content

Launch offerPay once, own it forever. Lifetime plans from ₹4,999, capped at the first 200 members.See lifetime plans →

Popular

    What Motilal Oswal BSE Healthcare ETF bought and sold in September 2026

    This compares the fund's portfolio at the end of September 2026 with the month before. Both come from the monthly portfolio statement of Motilal Oswal Mutual Fund.

    Motilal Oswal BSE Healthcare ETF Stocks Bought and Sold

    All changes are between August 2026 and September 2026

    More
    Stocks bought and sold in September 2026
    Sun Pharmaceutical Industries LimitedAdded+1.6%12.33%
    Divi's Laboratories LimitedAdded+1.6%7.42%
    Apollo Hospitals Enterprise LimitedAdded+1.6%5.21%
    Cipla LimitedAdded+1.6%4.79%
    Laurus Labs LimitedAdded+3.1%4.84%
    Dr Reddys Laboratories LimitedAdded+1.6%4.73%
    Max Healthcare Institute LimitedAdded+1.6%4.32%
    Torrent Pharmaceuticals LimitedReduced−16.2%3.55%
    Lupin LimitedAdded+1.6%3.11%
    Fortis Healthcare LimitedAdded+1.6%2.51%

    A change is counted by the number of shares the fund holds, not by price. A stock can become a smaller part of the fund in a month when the fund bought more of it, if its price fell. Debt papers are left out.

    Frequently Asked Questions

    Which new stocks did Motilal Oswal BSE Healthcare ETF buy in September 2026?

    It bought 16 new stocks: Ind-Swift Laboratories Limited (0.12%), Venus Remedies Limited (0.09%), Shukra Pharmaceuticals Limited (0.08%), Fredun Pharmaceuticals Ltd (0.06%), Amrutanjan Health Care Limited (0.05%), Anlon Healthcare Limited (0.05%), Sai Parenterals Limited (0.04%), NGL Fine Chem Limited (0.03%), MEDICAMEN BIOTECH LIMITED (0.02%) and One Global Service Provider Limited (0.02%). Each figure is the stock's share of the fund at the end of September 2026.

    Which stocks did Motilal Oswal BSE Healthcare ETF sell completely in September 2026?

    It sold all its shares in Health X Platform Limited (0.01%), Nectar Lifesciences Limited (0.01%) and Shree Ganesh Remedies Limited (0.01%). Each figure is the stock's share of the fund at the end of August 2026.

    Which stocks did Motilal Oswal BSE Healthcare ETF buy more of in September 2026?

    The largest increases in shares held were Corona Remedies Limited (+214.3%), Rubicon Research Limited (+114.5%), Nephrocare Health Services Ltd (+66.5%), Park Medi World Limited (+32.9%) and Emcure Pharmaceuticals Ltd (+24.3%). It added to 109 more.

    Which stocks did Motilal Oswal BSE Healthcare ETF sell part of in September 2026?

    The largest cuts in shares held were Anthem Biosciences Limited (−22.6%), Torrent Pharmaceuticals Limited (−16.2%), Eris LifeSciences Limited (−14.5%), Jagsonpal Pharmaceuticals Limited (−7.4%) and Windlas Biotech Limited (−1.4%). It reduced 3 more.

    How are these changes worked out?

    WealthGamma compares the number of shares Motilal Oswal BSE Healthcare ETF held on 30-09-2026 with 31-08-2026. Both figures come from the monthly portfolio statement of Motilal Oswal Mutual Fund. A change in share price alone does not count as buying or selling.

    See NAV, expense ratio and full holdings of Motilal Oswal BSE Healthcare ETF

    This page is information, not investment advice. Mutual fund investments are subject to market risks; read all scheme related documents carefully. Past returns do not promise future returns. Figures come from AMFI, NSE, BSE and each fund house's own documents.

    Track Motilal Oswal BSE Healthcare ETF in WealthGamma

    Add this fund once. WealthGamma updates its value every day and shows it next to your stocks, gold, deposits and loans.

    PAN not required · No broker linking · No OTPs